+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID04871191

Comparing Three Treatments for Adults with Granulomatosis With Polyangiitis Unresponsive to Standard Care

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-04-03

42

Participants Needed

1

Research Sites

21 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the best treatment options for patients with granulomatosis with polyangiitis GPA who do not respond well to standard therapies. This study aims to compare three salvage treatments to induce remission in these patients a combination of rituximab with a conventional disease-modifying antirheumatic drug cDMARD, tocilizumab, and tofacitinib. GPA is a type of inflammation affecting blood vessels, and managing patients with ongoing disease activity despite standard care remains challenging. The study involves three treatment groups. One group receives rituximab weekly for four weeks followed by maintenance doses at weeks 24 and 52, combined with a cDMARD chosen by the doctor preferably methotrexate, but azathioprine or mycophenolate mofetil may be used. Another group receives weekly subcutaneous injections of tocilizumab, and the third group takes oral tofacitinib twice daily starting at week 0 through week 52. Each treatment is studied to understand its ability to help patients achieve remission. Participants will be monitored regularly throughout the study, with key assessments at weeks 12, 24, 26, and 52. Researchers will evaluate responses including remission rates, disease activity as assessed by doctors and patients, patient-reported outcomes, and use of corticosteroids. Safety will be monitored by tracking adverse events and laboratory tests. The study is designed to last at least 52 weeks of treatment with detailed follow-up to better understand the effects of these therapies on GPA management.

CONDITIONS

Brief Title

Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis

Research Team

J

Jonathan London, MD

A

Alice CAMARA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here